- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Mazindol is a centrally-acting sympathomimetic amine used to treat gastrointestinal disorders. It is used to reduce the symptoms of nausea, vomiting, and abdominal pain associated with gastroenteritis. It is also used to treat irritable bowel syndrome (IBS) and other gastrointestinal disorders. Mazindol is available in both oral and intravenous forms. It is usually taken three times a day, with or without food.
Mazindol is a prescription drug and is available in generic and brand-name formulations. It is manufactured by several pharmaceutical companies, including Pfizer, Merck, and Novartis. It is also available in combination with other medications, such as antacids and antiemetics.
Mazindol is generally well-tolerated, but it can cause side effects such as dry mouth, dizziness, and drowsiness. It should not be used in patients with certain medical conditions, such as glaucoma, hypertension, and heart disease.
The Mazindol market is a niche market, with a limited number of manufacturers and suppliers. It is primarily used to treat gastrointestinal disorders, and is not widely used for other medical conditions.
Companies in the Mazindol market include Pfizer, Merck, Novartis, and other pharmaceutical companies. Show Less Read more